Search
Amylyx Pharmaceuticals Inc
AMLXAdd to Watchlist
15.670USD
+0.420+2.75%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.74BMarket Cap
LossP/E TTM
Amylyx Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Amylyx Pharmaceuticals Inc is 8.12, ranking 166 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -10.55, which is -4073.91% below the recent high of 419.35 and -87.71% above the recent low of -19.81.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
